Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Medtronic
Moodys
Merck
Boehringer Ingelheim

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Acrotech Biopharma, LLC v. Fresenius Kabi USA, LLC (D. Del. 2018)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Acrotech Biopharma, LLC v. Fresenius Kabi USA, LLC (D. Del. 2018)

Docket   Start Trial Date Filed 2018-10-03
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand None Referred To
Parties ACROTECH BIOPHARMA, LLC; FRESENIUS KABI ONCOLOGY LTD.; FRESENIUS KABI USA, INC.; FRESENIUS KABI USA, LLC; SPECTRUM PHARMACEUTICALS, INC.; TOPOTARGET UK LTD.
Patents 6,888,027; 8,835,501
Attorneys Alexandra M. Joyce; Aly T. Imron; Becky E. Steephenson; Brian E. Farnan; Brian R. Lemon; Daniel M. Silver; Gregory J. Manas; Helen H. Ji; Jack B. Blumenfeld; James R. Tyminski; Jeffrey J. Lyons; John K. Hsu; Stephen J. Smith; William E. Solander
Firms Farnan LLP; Morris, Nichols, Arsht & Tunnell; Morris, Nichols, Arsht & Tunnell LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Acrotech Biopharma, LLC v. Fresenius Kabi USA, LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Acrotech Biopharma, LLC v. Fresenius Kabi USA, LLC (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 U.S. Patent Nos. 6,888,027 (the “’027 patent”) and U.S. Patent No. 8,835,501 (the “’501 patent”) under…the ’027 patent and the ’501 patent, or any later expiration of exclusivity for the ’027 patent and the… THE PATENTS-IN-SUIT 28. On May 3, 2005, the ’027 patent, titled “Carbamic Acid…United States Patent and Trademark Office (“PTO”). A true and correct copy of the ’027 patent is attached…of the ’501 patent is attached as Exhibit B. 31. The claims of the ’501 patent are directed External link to document
0000-00-00 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) U.S. 6,888,027 ;U.S. 8,835,501.… 3 October 2018 1:18-cv-01533 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Dow
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.